慢性疼痛与致幻剂:综述及作用机制假说
本文综述了慢性疼痛的中枢敏化机制及经典致幻剂通过5-HT2A受体激动重置脑功能连接的可能镇痛机制。现有临床证据有限,但过去50年的研究和报告显示致幻剂在癌痛、幻肢痛和丛集性头痛中具有潜在镇痛获益,且安全性总体良好。鉴于阿片类药物危机和非阿片类镇痛药疗效有限,作者建议进一步开展致幻剂作为镇痛药的研究。
要点
- 致幻剂通过5-HT2A受体激动可能重置慢性疼痛相关的异常脑功能连接。
- 过去50年研究显示致幻剂在癌痛、幻肢痛和丛集性头痛中具有潜在镇痛获益。
- 致幻剂安全性总体良好,但临床证据有限,需进一步研究。
核心结论
- 经典致幻剂可能通过5-HT2A受体激动和改变脑功能连接发挥镇痛作用,值得进一步研究。
研究设计与样本
- 本文为综述,回顾了慢性疼痛机制、致幻剂作用机制及过去50年的临床证据。
主要发现
- 多项研究和报告显示致幻剂在癌痛、幻肢痛和丛集性头痛中具有潜在镇痛获益。
- 致幻剂的安全性总体良好,尤其与阿片类镇痛药相比。
临床怎么用
- 目前临床证据有限,致幻剂尚未成为慢性疼痛的常规治疗选择。
- 在阿片类药物危机背景下,可关注致幻剂作为非阿片类镇痛药的研究进展。
局限性
- 现有临床证据有限,作用机制尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The development of chronic pain is a complex mechanism that is still not fully understood. Multiple somatic and visceral afferent pain signals, when experienced over time, cause a strengthening of certain neural circuitry through peripheral and central sensitization, resulting in the physical and emotional perceptual chronic pain experience. The mind-altering qualities of psychedelics have been attributed, through serotonin 2A (5-HT2A) receptor agonism, to 'reset' areas of functional connectivity (FC) in the brain that play prominent roles in many central neuropathic states. Psychedelic substances have a generally favorable safety profile, especially when compared with opioid analgesics. Clinical evidence to date for their use for chronic pain is limited; however, several studies and reports over the past 50 years have shown potential analgesic benefit in cancer pain, phantom limb pain and cluster headache. While the mechanisms by which the classic psychedelics may provide analgesia are not clear, several possibilities exist given the similarity between 5-HT2A activation pathways of psychedelics and the nociceptive modulation pathways in humans. Additionally, the alterations in FC seen with psychedelic use suggest a way that these agents could help reverse the changes in neural connections seen in chronic pain states. Given the current state of the opioid epidemic and limited efficacy of non-opioid analgesics, it is time to consider further research on psychedelics as analgesics in order to improve the lives of patients with chronic pain conditions.
引用
- Castellanos JP, Woolley C, Bruno KA, et al. Chronic pain and psychedelics: a review and proposed mechanism of action. Reg Anesth Pain Med. 2020. PMID: 32371500. doi:10.1136/rapm-2020-101273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。